Synthesis and In Vitro Profiling of Psilocin Derivatives: Improved Stability and Synthetic Properties

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Drug Development

Background:

• Psilocybin therapy shows promise for mental health disorders.
• Current psilocybin production is complex and inefficient.
• Novel production methods are needed for wider therapeutic application.

Purpose of the Study:

• To evaluate psilocin ester prodrugs and psilocin salts as alternatives to psilocybin.
• To assess the ease of synthesis, chemical stability, and metabolic profiles of these compounds.
• To identify compounds with potential advantages over psilocybin for therapeutic use.

Main Methods:

• Synthesized a library of 15 psilocin ester prodrugs and 6 psilocin salts.
• Evaluated the synthesized compounds for stability, metabolic conversion to psilocin, and ease of synthesis.
• Compared the properties of these novel compounds against psilocybin.

Main Results:

• Several psilocin ester prodrugs and psilocin salts demonstrated desirable characteristics.
• Identified compounds exhibited good storage and handling stability.
• Key findings include rapid metabolic conversion to psilocin and simplified synthesis pathways.

Conclusions:

• Psilocin ester prodrugs and psilocin salts represent viable alternatives to psilocybin.
• These compounds offer potential advantages in production efficiency and stability.
• Further development of these psilocin derivatives could advance psilocybin-based therapies.